The global cervical cancer therapeutics market size was valued at USD 6.61 billion in 2025 and is projected to grow from USD 6.91 billion in 2026 to USD 9.80 billion by 2034, registering a compound annual growth rate (CAGR) of 4.47% during the forecast period from 2026 to 2034. North America dominated the cervical cancer therapeutics market in 2025, accounting for 38.2% of the global market...